-

5ÔÂÊ©ÐУ¡ÎÀ½¡Î¯È¨Íþ½â¶Á818ÌõÀý£¬ÖصãÐźÅÓÐÄÄЩ£¿
2026-03-04
ÐÜèÌåÓýÉúÎï818ÌõÀý5Ô¼´½«Ê©ÐУ¡2026Äê2ÔÂ24ÈÕ£¬¹ú¼ÒÎÀÉú½¡¿µÎ¯·¢²¼Ò»ÔòÖØÒª¹¤×÷¶¯Ì¬£º×öºÃ¡¶ÉúÎïҽѧм¼ÊõÁÙ´²Ñо¿ºÍÁÙ´²×ª»¯Ó¦ÓùÜÀíÌõÀý¡·¹á³¹Âäʵ£¬¸ßÖÊÁ¿Âú×ãÈËÃñȺÖÚ½¡¿µÐèÇó£¬Ö§³ÅÉúÎïÒ½Ò©²úÒµ¸ü¸ßˮƽ·¢Õ¹¡£ÖصãÐźÅÓÐÄÄЩ£¿
ÔĶÁÈ«ÎÄ -

±ðÖ»¿´¼¼Êõ·¾¶£¡ÐÜèÌåÓý¹ÙÍøÖÎÁƱä¸üµÄ¡°ÒþÐγɱ¾¡±ÓëÕ½ÂÔ¾ö²ß
2026-02-25
ÐÜèÌåÓýÉúÎï2026Äê1Ô£¬¹ú¼ÒÒ©¼à¾ÖÒ©Æ·ÉóÆÀÖÐÐÄÕýʽ·¢²¼¡¶ÐÜèÌåÓý¹ÙÍøÖÎÁÆÒ©Æ·Ò©Ñ§±ä¸üÑо¿ÓëÆÀ¼Û¼¼ÊõÖ¸µ¼ÔÔò£¨ÊÔÐУ©¡·£¨ÒÔϼò³Æ¡¶Ö¸ÄÏ¡·£©¡£ÕâÊǹúÄÚÊײ¿×¨ÃÅÕë¶ÔÐÜèÌåÓý¹ÙÍøÖÎÁÆÒ©Æ·Ò©Ñ§±ä¸üµÄרÏîÖ¸ÄÏ£¬ÎªCAR-T¡¢¸ÉÐÜèÌåÓý¹ÙÍø¡¢TILµÈ»îÐÜèÌåÓý¹ÙÍøÒ©Æ·µÄ¹¤ÒÕÓÅ»¯Óë¼¼ÊõÉý¼¶£¬ÌṩÁËÈ«¹úͳһµÄ¿ÆÑ§Â·¾¶Óë¼à¹Ü±ê×¼¡£ÎÒÃǼȽâ¶Á¡¶Ö¸ÄÏ¡·µÄºËÐļ¼ÊõÒªÇ󣬸üÕ¾ÔÚÕ½ÂÔ¾ö²ßÕßµÄÊӽǣ¬ËãÇåÐÜèÌåÓý¹ÙÍøÖÎÁƱä¸ü±³ºóµÄ¡°ÒþÐγɱ¾¡±Óë¡°Õ½ÂÔÑ¡Ôñ¡±¡£
ÔĶÁÈ«ÎÄ -

¹ØÓÚÐÜèÌåÓýÉúÎï 2026 Ä깩ӦÉÌ×ۺϺÏ×÷¹ÜÀíÊÂÏîµÄ¹«¸æ
2026-01-23
ÐÜèÌåÓýÉúÎïΪÌáÉýÓ빩ӦÉ̵ĺÏ×÷ЧÂÊ£¬½¨Á¢¿É³ÖÐøµÄºÏ×÷¹ØÏµ¡£ÐÜèÌåÓýÉúÎïÔ¸ÔÚ´ËÉêÃ÷¹«Ë¾µÄһЩ¹Ø¼ü²É¹º¹ÜÀí¹æ¶¨£¬Çë¸÷λ¹©Ó¦ÉÌÖÜÖª¡£ÇëÊÕµ½¸Ã¹«¸æµÄ¹©»õÉÌ£¬¼Ó¸Ç±¾ÆóÒµ¹«Õ£¬ÎļþɨÃèºó£¬ÇëÒÔ¹©Ó¦É̹«Ë¾×ܾÀíµÄÆóÒµÓÊÏäÐÎʽ·¢Ëͱ¾¹«Ë¾²É¹º¹ÜÀíÓÊÏä¡£»òÓÉÆäËû¾ßÓÐÏàÓ¦¹ÜÀíÖ°ÔðµÄÈËÔ±·¢ËÍ¡£Ò²·³Çë¸÷λ¹©»õÉ̽øÐÐÄÚ²¿Åàѵ£¬ÒÔÊÊÓ¦ÎÒ¹«Ë¾µÄºÏÀíÒªÇó¡£
ÔĶÁÈ«ÎÄ -

Clusterin-carrying extracellular vesicles derived from human umbilical cord mesenchymal stem cells restore the ovarian function of premature ovarian failure mice through activating the PI3K/AKT pathway
2026-01-15
ÐÜèÌåÓýÉúÎï¡¶ÈËÆê´ø¼ä³äÖʸÉÐÜèÌåÓý¹ÙÍøÀ´Ô´µÄÔØ¾Û¼¯ËØÐÜèÌåÓý¹ÙÍøÍâÄÒÅÝͨ¹ý¼¤»îPI3K/AKTͨ·»Ö¸´Ôç˥СÊóÂѳ²¹¦ÄÜ¡·£¬ÈËÆê´ø¼ä³äÖʸÉÐÜèÌåÓý¹ÙÍøÀ´Ô´µÄÔØ¾Û¼¯ËØÐÜèÌåÓý¹ÙÍøÍâÄÒÅÝͨ¹ý¼¤»îPI3K/AKTͨ·»Ö¸´Ôç˥СÊóÂѳ²¹¦ÄÜ£©¡£¸ÃÑо¿ÒÀÍÐÐÜèÌåÓý¼ä³äÖʸÉÐÜèÌåÓý¹ÙÍøÎÞѪÇåÅàÑø»ù£¨NC0103£©ÅàÑøÆê´ø¼ä³äÖʸÉÐÜèÌåÓý¹ÙÍø£¨UC-MSCs£©£¬ÉîÈë̽¾¿ÁËUC-MSCs¼°ÆäÑÜÉúµÄÐÜèÌåÓý¹ÙÍøÍâÄÒÅÝ£¨EVs£©¶Ô»¯ÁÆÓÕµ¼Âѳ²ÔçË¥£¨POF£©µÄÖÎÁÆ×÷ÓÃÓëÏà¹Ø»úÖÆ£¬ÎªPOFµÄÁÙ´²ÖÎÁÆÌṩÁËеÄ˼·ºÍ²ßÂÔ¡£
ÔĶÁÈ«ÎÄ -

An efficient protocol to generate placental chorionic plate-derived mesenchymal stem cells with superior proliferative and immunomodulatory properties
2026-01-15
ÐÜèÌåÓýÉúÎï¡¶Ò»ÖÖÓÐЧÉú³É¾ßÓÐÓÅÔ½ÔöÖ³ºÍÃâÒßµ÷½ÚÌØÐÔµÄÌ¥ÅÌÈÞëĤ°å¼ä³äÖʸÉÐÜèÌåÓý¹ÙÍøµÄ·½°¸¡·£¬¸ÃÑо¿ÒÀÍÐÐÜèÌåÓýMSCsÎÞѪÇåÅàÑø»ù£¨NC0103£©£¬³É¹¦ÅàÑø´ÓÌ¥ÅÌºÍÆê´ø·ÖÀëµÄCP-MSCs¡¢CV-MSCs¡¢D-MSCsºÍUC-MSCsµÈ¶àÖÖ¼ä³äÖʸÉÐÜèÌåÓý¹ÙÍø£¬¿ª·¢³ö¸ßЧµÄÌ¥ÅÌÈÞëĤ°å¼ä³äÖʸÉÐÜèÌåÓý¹ÙÍøÉú³É¼¼Êõ£¬ÎªÏà¹ØÁÙ´²Ó¦ÓÃÌṩÁËÇ¿Á¦Ö§³Ö¡£
ÔĶÁÈ«ÎÄ -

circCDK13-loaded small extracellular vesicles accelerate healing in preclinical diabetic wound models
2026-01-15
ÐÜèÌåÓýÉúÎï¡¶¸ºÔØcircCDK13µÄСÐÜèÌåÓý¹ÙÍøÍâÄÒÅݼÓËÙÁÙ´²Ç°ÌÇÄò²¡ÉË¿ÚÄ£ÐÍÓúºÏ¡·£¬¸ÃÑо¿ÒÀÍÐÐÜèÌåÓýÉúÎï¼ä³äÖʸÉÐÜèÌåÓý¹ÙÍøÎÞѪÇåÅàÑø»ù£¨NC0103£©Íê³ÉCP-MSCsµÄÎȶ¨ÅàÑø¼°ºóÐø¹¤³Ì»¯sEVsÖÆ±¸£¬¾Û½¹ÌÇÄò²¡ÉË¿ÚÓúºÏÁìÓòÈ¡µÃ¹Ø¼üÍ»ÆÆ¡£
ÔĶÁÈ«ÎÄ -

´ÅÖé·¨ or ÈÈÁѽⷨ£¿ÄãµÄÐÜèÌåÓý¹ÙÍø²úÆ·ÖʿؿÉÄÜÑ¡´íÁË£¡
2025-12-30
ÐÜèÌåÓýÉúÎïÔĶÁÈ«ÎÄ -

Í»ÆÆÖÆÔìÆ¿¾±£ºCAR-TÐÜèÌåÓý¹ÙÍøÁÆ·¨µÄÖÊÁ¿¸ïÐÂÓëÁ¿²ú֮·
2025-12-09
ÐÜèÌåÓýÉúÎïCAR-TÐÜèÌåÓý¹ÙÍøÁÆ·¨×÷ΪÖ×ÁöÃâÒßÖÎÁÆÁìÓòµÄ¸ïÃüÐÔÍ»ÆÆ£¬Îª¸´·¢/ÄÑÖÎÐÔѪҺϵͳ¶ñÐÔÖ×Áö»¼Õß´øÀ´ÁËеÄÏ£Íû£¬ÔÚCAR-TÒ©ÎïÉú²ú·½Ã棬ÐÐÒµ¹²Ê¶ÔÚÓÚ±ØÐ뽫¡°ÖÊÁ¿Ô´ÓÚ¼ìÑ顱Éý¼¶Îª¡°ÖÊÁ¿Ô´ÓÚÉè¼Æ¡±£¨Quality by Design, QbD£©µÄǰհÐÔÉè¼ÆÀíÄî¡£×÷ΪÕâÒ»±ä¸ïµÄ¼ùÐÐÕߣ¬ÐÜèÌåÓýÉúÎïͨ¹ýFEPÐÜèÌåÓý¹ÙÍøÅàÑø´üµÄ´´ÐÂÑз¢£¬½«QbDÀíÄîÉî¶ÈÈÚÈë²úÆ·Éè¼ÆµÄÿ¸ö»·½Ú£¬ÎªÐÐÒµÌṩÁËÒ»Ì×ϵͳÐԵĽâ¾ö·½°¸¡£
ÔĶÁÈ«ÎÄ -

ÄêÁä²»ÊÇÕϰ£ºµÍ²ÉѪÁ¿NKÐÜèÌåÓý¹ÙÍø¼¼Êõ£¬Îª¸ßÁ仼Õß´ò¿ªÃâÒßÖÎÁÆÐ´°
2025-12-05
ÐÜèÌåÓýÉúÎïNKÐÜèÌåÓý¹ÙÍøÁÆ·¨×÷ΪһÖÖÓÐǰ¾°µÄÖ×ÁöÃâÒßÖÎÁÆ£¬ÆäÉú²úͨ³£ÒÀÀµ´Ó»¼ÕßÍâÖÜѪÖлñÈ¡×ã¹»ÊýÁ¿µÄÆðʼÐÜèÌåÓý¹ÙÍø¡£È»¶ø£¬´«Í³NKÐÜèÌåÓý¹ÙÍøÁÆ·¨Ðè²É¼¯´óÁ¿ÍâÖÜѪ£¨30-50ºÁÉýÒÔÉÏ£©£¬¶Ô¸ßÁä¡¢ÌåÈõµÄÖ×Áö»¼ÕßÔì³ÉÏÔÖøµÄÉúÀíÓëÐÄÀí¸ºµ£¡£µÍ²ÉѪÁ¿¼¼ÊõÍ»ÆÆÐԵؽ«²ÉѪÐèÇó½µÖÁ5-15ºÁÉý£¨Ï൱ÓÚ³£¹æ¼ì²éÁ¿£©£¬´ó·ù½µµÍÁË»¼ÕßµÄѪÈÝÁ¿²¨¶¯·çÏպͿ־åÐÄÀí£¬ÓÐЧÌáÉýÁËÖÎÁư²È«ÐÔÓë½ÓÊܶȣ¬Ê¹¸ü¶à´àÈõ»¼ÕßÄܹ»ÊÜÒæÓÚ¸ÃÃâÒßÁÆ·¨¡£
ÔĶÁÈ«ÎÄ -

ÐÜèÌåÓýÉúÎ﹫¿ªÈ«Ïß²úƷĿ¼¼Û¸ñµÄÉùÃ÷
2025-12-01
ÐÜèÌåÓýÉúÎïÐÜèÌåÓýÉúÎï±ü³Ö³¤ÆÚÀíÄ¿´ÖØÓë¿Í»§µÄ³¤ÆÚ³ÖÐøºÏ×÷£¬¶ø·Çijһ´ÎµÄºÏ×÷¡£È·±£¿Í»§µÄÿһ´Î²É¹º¶¼ÊÇÂúÒâµÄ£¬ÊÇÎÒÃÇÒ»Ö±ÒÔÀ´µÄ×·Çó¡£Ö®Ç°ÓÉÓÚȱ·¦¼Û¸ñ֮꣬µ¼ÖÂһЩ¿Í»§Ôڳɽ»ºóÒ²ÐÄÇéÖ¾ìý£¬Î¨¿Ö×Ô¼ºÂò¹ó¡£´ËµÈ²É¹º¸ÐÊÜ£¬ÄÑÑÔÓä¿ì¡£ÐÜèÌåÓýÉúÎïÓÐÒåÎñ½â¾ö¿Í»§µÄÀ§ÈÅ¡£
ÔĶÁÈ«ÎÄ
